- Rockwell Medical (NASDAQ:RMTI +11.4%) Q2 results: Revenues: $13M (-0.5%); COGS: $10.9M (-0.9%); R&D Expense: $0.9M (+350.0%); SG&A: $3.8M (-9.5%); Operating Loss: ($2.7M) (-12.5%); Net Loss: ($2.5M) (+21.9%); Loss Per Share: ($0.05) (+37.5%); Quick Assets: $37.1M (-43.6%).
- No guidance given.
Rockwell Medical reports Q2 results
Recommended For You
About RMTI Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
RMTI | - | - |
Rockwell Medical, Inc. |